SHARE TRANSFER AGREEMENTShare Transfer Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations
THIS AGREEMENT WITNESSES THAT in consideration of the settlement of indebtedness totalling US $217,500, being a portion of the indebtedness owed to the Transferee by the Transferor, and in reliance of the representations and warranties of the Transferee, the Transferor hereby sells, assigns and transfers to the Transferee 2,500,000 common shares (the “Shares”) of Ovation Science Inc. (the “Company”), as constituted on the date hereof.
TERRY HOWLETT VOTING AND SUPPORT AGREEMENTTerry Howlett Voting and Support Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
This VOTING AND SUPPORT AGREEMENT (hereinafter referred to as this “Agreement”), dated as of March 18, 2018, is by and among the Quoin Pharmaceuticals, Inc., a Delaware corporation (“Quoin”) and Terry Howlett (“Stockholder”).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION by and among SKINVISIBLE, INC., QUOIN MERGER SUB, INC., QUOIN PHARMACEUTICALS, INC., Dated as of March 26, 2018Agreement and Plan of Merger And • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of March 26, 2018, by and among Skinvisible, Inc., a Nevada corporation (referred to as “Parent”), Quoin Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”), Quoin Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 8.14.
MICHAEL MYERS LOCK-UP AGREEMENTMichael Myers Lock-Up Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
This LOCK-UP AGREEMENT (this “Agreement”), dated as of March 18, 2018, is being executed and delivered as of March 18, 2018, by Michael Myers (“Stockholder”) in favor of and for the benefit of Skinvisible, Inc., a Nevada corporation (“Parent”).
DENISE CARTER LOCK-UP AGREEMENTDenise Carter Lock-Up Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
This LOCK-UP AGREEMENT (this “Agreement”), dated as of March 18, 2018, is being executed and delivered as of March 18, 2018, by Denise Carter (“Stockholder”) in favor of and for the benefit of Skinvisible, Inc., a Nevada corporation (“Parent”).
DOREEN MCMORRAN VOTING AND SUPPORT AGREEMENTDoreen McMorran Voting and Support Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
This VOTING AND SUPPORT AGREEMENT (hereinafter referred to as this “Agreement”), dated as of March 18, 2018, is by and among the Quoin Pharmaceuticals, Inc., a Delaware corporation (“Quoin”) and Doreen McMorran (“Stockholder”).
TERRY HOWLETT LOCK-UP AGREEMENTTerry Howlett Lock-Up Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
This LOCK-UP AGREEMENT (this “Agreement”), dated as of March 18, 2018, is being executed and delivered as of March 18, 2018, by Terry Howlett (“Stockholder”) in favor of and for the benefit of Quoin Pharmaceuticals, Inc., a Delaware corporation (“Quoin”).
SHARE TRANSFER AGREEMENTShare Transfer Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations
THIS AGREEMENT WITNESSES THAT in consideration of the settlement of indebtedness totalling US $5,000, being a portion of the indebtedness owed to the Transferee by the Transferor, and in reliance of the representations and warranties of the Transferee, the Transferor hereby sells, assigns and transfers to the Transferee 57,500 common shares (the “Shares”) of Ovation Science Inc. (the “Company”), as constituted on the date hereof.
DOREEN MCMORRAN LOCK-UP AGREEMENTLock-Up Agreement • March 29th, 2018 • Skinvisible Inc • Pharmaceutical preparations • Delaware
This LOCK-UP AGREEMENT (this “Agreement”), dated as of March 18, 2018, is being executed and delivered as of March 18, 2018, by Doreen McMorran (“Stockholder”) in favor of and for the benefit of Quoin Pharmaceuticals, Inc., a Delaware corporation (“Quoin”).
